Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands ...

Explore why XLRE REITs face challenges with rising rates & poor returns. Discover better investment opportunities beyond ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Is it time to bargain hunt? On-again, off-again policies from Washington, the onset of global tariff salvos, and flagging ...